Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Shooting at Australia's Bondi Beach kills 12
Police hold person of interest after Brown University shooting leaves two dead
Hamas says Israel's killing of senior commander threatens ceasefire
Ukraine's Zelenskyy ditches NATO ambition ahead of peace talks
